Mobileye Global surged on better-than-expected Q1 sales and strong Q2 sales guidance, leading to analyst price target increases. Palantir Technologies stock gained 20.26% last week amid recent defense partnerships. Today's manic market swings are creating the perfect setup for Matt's next ...

The past week has been a rollercoaster ride for the autonomous driving and electric vehicle ( EV ) sectors. From President Trump's change of heart on autonomous vehicles to Jeff Bezos-backed EV startups making waves, the industry has seen significant developments. Let's dive into the top stories ...

Tesla ( NASDAQ: TSLA ) just released fresh financials for the three-month period that ended March 31. Investors were looking for some upbeat news, which isn't surprising when you consider the fact that shares have crashed 35% in 2025 ( as of April 24 ) .But the top electric vehicle ( EV ) maker's ...

Rivian Automotive ( NASDAQ: RIVN ) shares trade at a significant discount to peers such as Lucid Group and Tesla. Yet the electric vehicle ( EV ) maker's sales have huge growth potential, with a sales inflection point likely occurring within the next 12 months.But before you jump into this ...

Only firm opposition from a united international community will convince the US to change its current course of action.

While top executives like Mark Zuckerberg and Jamie Dimon sold off hundreds of millions in stock before markets tanked, Barstool Sports founder Dave Portnoy says he took the hit right along with everyone else.

Warren Buffett is highly respected in the investment world for good reason: He has increased the value of his company, Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) , by an annual average of nearly 20% over close to 60 years.

Investors might be worried because the S&P 500 index is down 7% so far in 2025 ( as of April 24 ) . There's a general level of fear out there, specifically about the direction the economy is headed in. In fact, more people are expecting a recession to happen.Ford Motor Company ( NYSE: F ) has ...

CORAL GABLES, Fla., April 27, 2025 ( GLOBE NEWSWIRE ) -- Relmada Therapeutics, Inc. RLMD "Relmada", "the Company" ) ) , a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association ( AUA2025 ) , taking place from April 26-29th in Las ...

Data to be presented in Clinical Trials in Progress Session on Monday, April 28, 2025 Data to be presented in Clinical Trials in Progress Session on Monday, April ...